CCL17 and neoplasm: Together, these results indicate that STAT6 mutant rrDLBCL cells remodel their tumor microenvironment (TME) via the secretion of the chemokine CCL17 to attract CD4+ T-cells, although the subtype of CD4+ T-cells which were recruited were not determined in this study.